Tag: TNF inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to TNF inhibitors

Survey of Clinicians: Lower Cost of Biosimilars is the Main Driver of Treatment Choice in IBD

Added to Collection on: 2024-09-07 11:06:02

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Autoimmune diseases
TNF inhibitors
Disease-modifying antirheumatic drugs
Biosimilar
Infliximab
Biopharmaceutical
Adalimumab
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
Etanercept Biosimilar Insight Market Report 2024: Pipeline

Added to Collection on: 2024-09-19 14:24:15

Tags for this article:

Immunosuppressants
Disease-modifying antirheumatic drugs
TNF inhibitors
Arthritis
Autoimmune diseases
Etanercept
Biosimilar
Biopharmaceutical
Spondyloarthritis
Rheumatoid arthritis
Psoriasis
Psoriatic arthritis

Click the tags to see associated articles and topics

View Article Details
The impact of EU public procurement regulations on tenders in Spain: a study with adalimumab

Added to Collection on: 2024-09-19 09:42:24

Tags for this article:

Pharmaceutical industry
Pharmaceuticals policy
Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Biosimilar
Adalimumab
Government procurement
Biopharmaceutical
E-procurement
Medication
Generic drug
Spain

Click the tags to see associated articles and topics

View Article Details
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions

Added to Collection on: 2024-10-31 13:05:31

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Pharmacy
Biosimilar
Biopharmaceutical
Psoriasis
Adalimumab
Ustekinumab
Etanercept
Amgen
Robert Popovian
United States
Stelara

Click the tags to see associated articles and topics

View Article Details
Biosimilars Month in Review: October 2024 - HCPLive

Added to Collection on: 2024-11-02 18:03:59

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Janssen Biotech
Biosimilar
Adalimumab
Infliximab
Ustekinumab
Etanercept
Ulcerative colitis
Crohn's disease

Click the tags to see associated articles and topics

View Article Details
Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with ...

Added to Collection on: 2025-02-10 17:23:39

Tags for this article:

Monoclonal antibodies
TNF inhibitors
Biotechnology
Janssen Biotech
Biopharmaceutical
Pharmacy
Golimumab
Biosimilar
Intas Pharmaceuticals
Pharmaceutical industry in India
Psoriatic arthritis
Bio-Thera Solutions
Thera Solutions, Ltd.
United States
Simponi Aria
Accord BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
From Amjevita to Zarxio: A Decade of US Biosimilar Approvals

Added to Collection on: 2025-03-06 22:30:44

Tags for this article:

Specialty drugs
Orphan drugs
Biopharmaceuticals
Biosimilar
Immunosuppressants
TNF inhibitors
Association for Accessible Medicines
Adalimumab
Sandoz
Insulin glargine
Amgen
Bevacizumab

Click the tags to see associated articles and topics

View Article Details
Bioengineered Protein Drugs Market Size to Cross USD 672.7 - GlobeNewswire

Added to Collection on: 2025-03-13 22:07:55

Tags for this article:

Pharmacy
Disease-modifying antirheumatic drugs
Immunosuppressants
TNF inhibitors
Biotechnology
Biopharmaceutical
Biosimilar
Biocon
Pharmaceutical industry
Etanercept
Adalimumab
Amgen
United States
Wilmington

Click the tags to see associated articles and topics

View Article Details
Pfizer's IXIFI® will be available in Canada as of April 1, 2025 - The Globe and Mail

Added to Collection on: 2025-03-17 16:39:04

Tags for this article:

Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Autoimmune diseases
Janssen Biotech
Infliximab
Ulcerative colitis
Arthritis
Psoriatic arthritis
Psoriasis
Adalimumab
Biopharmaceutical
pfizer canada

Click the tags to see associated articles and topics

View Article Details
Pfizer's IXIFI® will be available in Canada as of April 1, 2025 - Newswire.ca

Added to Collection on: 2025-03-17 16:10:04

Tags for this article:

Autoimmune diseases
Abdominal pain
Immunosuppressants
Monoclonal antibodies
TNF inhibitors
Infliximab
Pfizer
Biosimilar
Inflammatory bowel disease
Biopharmaceutical
Crohn's disease
Ulcerative colitis
Pfizer Inc.
Canada

Click the tags to see associated articles and topics

View Article Details